BIOMAT Database Logo BIOMAT Database Logo

Profiling of proteome changes in plasma of HIV-infected patients receiving antiretroviral therapy. 2022

Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
School of Life Sciences, Tsinghua University, Beijing, China.

Antiretroviral therapy (ART) prevents human immunodeficiency virus (HIV)-1 onward transmission and disease progression, leading to excellent prognosis in people living with HIV-1 (PWH). However, side effects, complications, and impaired immune reconstitution persist in some patients treated with ART. We aimed to profile proteome changes in plasma before and after ART to identify the molecular pathways altered by ART. Quantitative proteomics analysis based on tandem mass tag (TMT) labeling was used to profile proteome changes of paired plasma samples from HIV-1 patients before receiving ART and after ART treatment. A total of 1398 protein groups (PGs) were identified, in which 18 proteins were downregulated and 50 were upregulated in plasma from ART treated patients. Based on Ingenuity Pathway analysis (IPA), gap junction signaling and actin cytoskeleton signaling were enriched among upregulated proteins, while downregulated proteins were mainly participated in IL-15 signaling pathway. Patients with the low level of CSF1R and the high levels of MINPP1 and TGM3 showed better CD4+ T-cell recovery. The present study provided plasma proteome changes after ART to elucidate the underlying mechanistic pathways in response to ART, and also identified potential targets to prompt immune reconstitution.

UI MeSH Term Description Entries
D011503 Transglutaminases Transglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain. They include keratinocyte transglutaminase (TGM1 or TGK), tissue transglutaminase (TGM2 or TGC), plasma transglutaminase involved with coagulation (FACTOR XIII and FACTOR XIIIa), hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site (YGQCW) and strict CALCIUM dependence. Glutaminyl-Peptide Gamma-Glutamyltransferases,Protein-Glutamine gamma-Glutamyltransferases,Transglutaminase,Gamma-Glutamyltransferases, Glutaminyl-Peptide,Glutaminyl Peptide Gamma Glutamyltransferases,Protein Glutamine gamma Glutamyltransferases,gamma-Glutamyltransferases, Protein-Glutamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D020543 Proteome The protein complement of an organism coded for by its genome. Proteomes
D023241 Antiretroviral Therapy, Highly Active Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor. Combination Antiretroviral Therapy,HAART,Highly Active Antiretroviral Therapy,Antiretroviral Therapies, Combination,Antiretroviral Therapy, Combination,Combination Antiretroviral Therapies,Therapies, Combination Antiretroviral,Therapy, Combination Antiretroviral
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Profiling of Inflammatory Proteins in Plasma of HIV-1-Infected Children Receiving Antiretroviral Therapy.
September 2020, Proteomes,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Gynecomastia in HIV-infected patients receiving antiretroviral therapy.
September 2003, AIDS research and human retroviruses,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy.
October 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
October 2004, Antiviral therapy,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy.
July 2012, JAMA,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Anemia in HIV-infected patients receiving highly active antiretroviral therapy.
January 2002, Journal of acquired immune deficiency syndromes (1999),
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
August 2004, The Journal of the Association of Physicians of India,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.
November 2014, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy.
April 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Ting Li, and Hong Qu, and Haibo Ding, and Haiteng Deng, and Yuling Chen
[MEDICO-SOCIAL CHARACTERISTIC OF HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY].
January 2015, Klinicheskaia meditsina,
Copied contents to your clipboard!